SCHEMBL22742800

SCHEMBL22742800

CCn1c2ccccc2c2ccc(N(c3ccccc3)c3ccc4cc5c(cc4c3)oc3c5ccc4c5cc6ccc(N(c7ccccc7)c7ccc8c9ccccc9n(CC)c8c7)cc6cc5oc43)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.39
▸ MAPT P10636 6/20 0.36
▸ KDM4E B2RXH2 5/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ HPGD P15428 4/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ HTT P42858 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HBB P68871 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NPY5R Q15761 5/20 0.35
▸ PER2 O15055 1/20 0.34
▸ CRY1 Q16526 1/20 0.34
▸ CRY2 Q49AN0 1/20 0.34
▸ GAA P10253 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22742799 0.95 KDM4E (0.41) KDM1AMAPTKDM4EALDH1A1HPGD
SCHEMBL22740351 0.94 KDM1A (0.41) KDM1AMAPTKDM4EALDH1A1HPGD
SCHEMBL22740459 0.93 CYP1A2 (0.36) KDM1AMAPTKDM4EALDH1A1HPGD
SCHEMBL22741010 0.93 KDM1A (0.40) KDM1AMAPTKDM4EALDH1A1HPGD
SCHEMBL22742912 0.89 KDM1A (0.39) KDM1AMAPTKDM4EALDH1A1HPGD
SCHEMBL22740458 0.88 KDM4E (0.37) KDM1AMAPTKDM4EALDH1A1HPGD
SCHEMBL22742797 0.87 CYP1A2 (0.34) KDM1AMAPTKDM4EALDH1A1HPGD
SCHEMBL22740044 0.87 GPR3 (0.36) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL22740350 0.87 KDM4E (0.43) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL24000221 0.87 KDM1A (0.41) KDM1AMAPTKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377513-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377513-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, TMEM109, LEF1 KDM1A 1474/4885MAPT 2589/4885KDM4E 3079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback